Ireland is a beautiful green country located in northwest Europe. It is an island that is separated from Great Britain by the Irish Sea. The island is considered the 20th largest island in the world,
Its currency is the Euro. The country’s official language is both English and Irish.Northern Ireland is governed by the United Kingdom, while the rest of Ireland is an independent nation.
Dublin City University is located in the north of Dublin city centre and a short bus ride to the heart of this vibrant capital city of over 1 million people.
DCU is internationally recognised as a top young university, being both a QS Top 100 under 50 and THE Top 150 under 50. We have an extensive range of courses, including Undergraduate Programmes of 3-4 years, 1-year taught Masters programmes, research programmes and Study Abroad programmes.
DCU is Ireland’s most innovative university, and in 2016 will deliver more than 200 programmes to over 16,000 students across its five faculties – Humanities and Social Sciences, Science and Health, Engineering and Computing, DCU Business School and the DCU Institute of Education.
In the last nine years, DCU has twice been named Sunday Times ‘University of the Year’.
European headquarters of the topmost world companies are in Ireland: Apple, Google, HP, IBM, Twitter, Facebook, PayPal, TCS, Infosys, 100s more
24 months work visa in Ireland available after graduation.
MSc in Diagnostics and Precision Medicine::
The MSc in Diagnostics and Precision Medicine is a new blended-learning programme that details how diagnostics and therapeutics are revolutionising healthcare and medicine by providing the right person with the right therapy at the right time.
Recent advances in the understanding of normal and diseased states has led to revolutionary new treatments for conditions such as cancer, inflammatory diseases and inherited diseases.
Furthermore, advances in science and technology have resulted in the development of new biomedical assays to (a) diagnose diseases and conditions more accurately (b) classify disease more precisely (c) approach treatment more individually and (d) identify who is at risk of developing a disease or condition.
Such advances in diagnostics and therapeutics have ushered in an exciting new era known as Precision Medicine, which refers to prevention and treatment strategies that takes patient variability into account (people’s genes, environment and lifestyles) by providing the right patient with the right medicine at the right time. As an example, the treatment of several cancers have shifted away from the “One-Size-Fits-All” approach of treatment (e.g. chemotherapy) to a more focused and tailored strategy where targeted therapies are matched according to the molecular profile of a patient’s tumour. In this situation, variations in the sequence, structure or expression of that person’s DNA, RNA or protein (i.e. biomarkers) are analysed using clinically-validated diagnostic assays (commonly referred to as Companion Diagnostics) and used to stratify patients so that those who are likely to benefit from these therapies are identified and treated, while who are unlikely to benefit (and may experience unnecessary side effects) can receive alternative treatments. Similarly, molecular diagnostic assays are increasing used to predict the outcome of a patient’s disease (prognosis), and therefore medical treatments can be tailored accordingly.
The programme is aimed at:
.Life scientists (including newly qualified graduates)
.Professionals from the diagnostics, biopharmaceutical, pharmaceutical and healthcare industries
.Medical Practitioners (including General Practitioners and clinicians-in-training)
Who wish to:
.Develop and broaden their knowledge of how new therapies including targeted therapeutics, cell-based therapies and gene modulation technologies are revolutionising the treatment of diseases such as cancer, inflammatory diseases and inherited diseases
.Understand how the integration of diagnostics and therapeutics are changing the landscape of healthcare and medicine through Precision Medicine
.Pursue a career in the biomedical diagnostics, biomedical science and biopharmaceutical industries
.Develop/consolidate their research skills with a view to undertaking further research (e.g. PhD or MD)
.Develop their critical analysis skills and enhance their professional development
Careers::
Graduates will find employment in industry, clinical, healthcare and academic environments. This includes the diagnostics and biopharmaceutical industries, life science and clinical trials companies, as well as academic research centres.
|
